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To define the in vivo relation between abnormal wall 
motion and the area at risk for necrosis after acute coro•
nary occlusion, 11 open chest dogs were studied. Five 
dogs underwent left anterior descending coronary artery 
occlusion and six underwent left circumflex artery oc•
clusion. Area at risk was defined at five short-axis levels 
(mitral valve, chordal, high and low papillary muscle 
and apex) using myocardial contrast echocardiography. 
Wall motion was measured in the cycles preceding in•
jection of contrast medium. Two observers used two 
different methods to measure wall motion. In method 
A, end-diastolic to end-systolic fractional radial change 
for each of 32 endocardial targets was determined. The 
extent of abnormal wall motion was then calculated using 
three definitions of wall motion abnormality: 1) akine•
sia/dyskinesia, 2) fractional inward endocardial excur•
sion of less than 10%, and 3) fractional inward endo•
cardial excursion of less than 20%. In method B. the 
information from the entire systolic contraction sequence 
was analyzed and correlated with a normal contraction 
pattern. 
The best linear correlation between area at risk (AR) 
Two-dimensional echocardiography has been demonstrated 
(1-14) to be a sensitive and accurate technique for detecting 
and quantitating the abnormal wall dynamics that occur 
From the Massachusetts General Hospital. Cardiac Umt and Harvard 
Medical School, Boston, Massachusett,. This study was supported In part 
by Grants HL 07535. HL 26215 and HL 21751 from the NatIonal Institute, 
of Health, Bethesda, Maryland. Dr. Okada IS an E,tablished InvestIgator 
of the American Heart AssoCialion, Dallas, Texa,. This study wa, pre•
sented In part at the 57th Annual Scientific SessIOns of the American Heart 
AssociatIOn, Miami Beach, Florida, November 1984 
Manw,crlpt received December 26, 1984: revised manu,cnpl received 
July 30, 1985. accepted August 8, 1985 
Addre,s for reprints' Arthur E. Weyman, MD, Non-InvaSive Cardiac 
Laboratory, Massachusetts General Hospital, Boston, Ma~>i>achusett, 02114 
*Pre,ent address. Divl'lon of Cardiology (Box 158), Umver~ily 01 
Virgima School of Medicine, Charlottesville, VirgInia 22903 
C<j 1986 by the Amencan College ot CardIOlogy 
and abnormal wall motion (A WM) was achieved using 
method B and expressed by the following linear regres•
sion: A WM = 0.92 AR + 3.0 (r = 0.92, p < 0.0001, 
SEE = 1.7%). Of the three definitions of abnormality 
used in method A, the best correlation was achieved 
between area at risk and less than 10% inward endo•
cardial excursion and was expressed by the following 
polynomial regression: A WM = - 0.01 AR2 + 1.5 AR 
-0.14 (r = 0.92, p < 0.001, SEE = 1.7%). 
These data demonstrate that there is a definite re•
lation between area at risk and abnormal wall motion 
but that this relation varies depending on the method 
used to analyze wall motion. However, wall motion dur•
ing acute ischemia is also influenced by the loading con•
ditions of the heart. Because these may vary in a manner 
that is independent of the ischemic process, measure•
ment of both risk area and abnormal motion may pro•
vide a more comprehensive assessment of cardiac func•
tion in myocardial ischemia than is provided by the 
measurement of either alone. 
(J Am Coli CardioI1986;7:383-92) 
during myocardial ischemia or after infarction, In previous 
studies (1-9), a good overall correlation was demonstrated 
between the circumferential extent of echocardiographically 
defined abnormal wall motion or thickening and postmortem 
estimates of infarct size or the perfusion territory of a coro•
nary artery. Exact comparisons between wall motion in the 
beating, pressure-distended heart and postmortem estimates 
of risk area or infarct size are, however, inherently limited 
by difficulties in the precise registration of the in vivo data 
with in vitro anatomic sections. Further, postmortem sam•
ples provide only one time point to which the continuously 
evolving zone of dysfunction can be related. 
Recent studies (15-20) have shown that contrast myo•
cardial echocardiography is uniquely able to define the per-
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fusion territory of a coronary artery (area at risk) in the 
beating heart, The addition of this technique to standard 
echocardiographic imaging therefore provides an opportu•
nity to assess, in vivo, the correlation between the area at 
risk and the extent of ischemia-associated wall motion ab•
normalities, Although such comparisons have been at•
tempted recently (17-20), the precise relation between the 
extent and magnitude of abnormal wall motion and area at 
risk has not been defined, In the present study, we have 
attempted to correlate the area at risk determined by myo•
cardial contrast echocardiography with the extent of abnor•
mal wall motion using two methods of quantitative analysis 
of systolic radial shortening, 
In the first method (method A), only two points in the 
cardiac cycle were analyzed: end-diastole and end-systole, 
The second method (method B) integrated information from 
the entire systolic contraction sequence using a previously 
described method that correlates observed motion with a 
normal contraction pattern, The results of these comparisons 
indicate that there is a definite, although not precise, relation 
between abnormal wall motion and area at risk and that the 
best correlation is achieved when wall motion is analyzed 
using the entire systolic contraction sequence, 
Methods 
Animal preparation. Eleven mongrel dogs that weighed 
22 ± 5 kg (mean ± SD) were anesthetized with intravenous 
sodium pentobarbital (30 mg/kg body weight), intubated 
and ventilated with a Harvard respirator. A median ster•
notomy was performed and the heart suspended in a peri•
cardial cradle. Catheters were placed in the aorta and left 
ventricle for hemodynamic monitoring. Electrocardio•
graphic leads were attached in a standard manner. Hemo•
dynamic and electrocardiographic monitoring was per•
formed using a multichannel recorder (Sanborn 7700, Hewlett•
Packard Corporation). 
The left main, left anterior descending and left circumflex 
coronary arteries were carefully dissected free from the sur•
rounding tissues and ties were placed loosely around them. 
An electromagnetic flow probe (no. 2.0, Statham Instru•
ments Corporation) was placed snugly around the proximal 
left anterior descending artery and baseline coronary flow 
was recorded using a flow meter (SP 2202, Statham Instru•
ments Corporation). The right femoral artery was exposed 
and an 8F catheter was introduced into it and positioned in 
the descending aorta. This catheter was then attached to a 
Silastic tubing (internal diameter 0.1875 inch [0.48 em]; 
Dow Corning Corporation) connected to a Gregg cannula 
by a roller pump. This system was primed with 0.9% sodium 
chloride and the Gregg cannula introduced into the ascend•
ing aorta through the left common carotid artery. The roller 
pump was then started at a flow rate of 100 mllmin. The 
tip of the Gregg cannula was carefully introduced into the 
left main coronary artery and firmly secured with a silk tie. 
The roller pump was then adjusted so that the flow measured 
by the flow probe in the left anterior descending artery after 
cannulation was similar to that at baseline (Fig. I). The 
Gregg cannula was used to allow adequate mixing and thus 
prevent streaming of the contrast agent. 
Two-dimensional echocardiographic studies. These 
studies were performed using a commerCially available me•
chanical sector scanning system with a 5 MHz transducer 
(ATL Mark III or Diasonics CY 100). Images were recorded 
on videotape using a 0.5 inch (1.27 cm) YHS recorder 
(Panasonic NY 8200). Short-axis views at the following 
levels were obtained for analysis: mitral valve, chordal, high 
papillary muscle, low papillary muscle and apical. The 
transducer was manually moved from the base to the apex 
of the heart so that the cross sections obtained were parallel 
to each other and perpendicular to the long axis of the left 
ventricle. A saline bath was used to provide an acoustic 
interface between the transducer and the beating heart. The 
Figure 1. Diagrammatic representation of the canine model used 
in our study (see text for details). L. = left; R. = right. 
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bath was created by attaching the edges of a polyethylene 
sheet to the sternal edges and suspending it to cover the 
anterior cardiac surface; this plastic trough was filled with 
0,9% sodium chloride. 
Contrast agent. An agitated mixture of equal amounts 
of saline and Renografin-76 (diatrizoate meglumine and dia•
trizoate sodium, 18.5 g/50 ml, E.R. Squibb and Sons) was 
used as a myocardial blood flow marker based on its ability 
to enhance echo intensity as described by Tei et al. (20). 
To define area at risk for each echocardiographic short-axis 
level, 2 ml of the mixture was injected into the Gregg 
cannula. For each study, a total of five such injections were 
made at 5 minute intervals. 
The recorded images were analyzed on a commercially 
available off-line analysis system (Microsonics Easy View 
II, Microsonics Corporation). The video recordings were 
initially analyzed to select cycles in which the left ventricular 
myocardium was optimally visualized both before and after 
the injection of contrast medium. Selected cycles were trans•
ferred to a video disc system (Sony SVM 1010) for detailed 
analysis. 
Quantitation of area at risk. In order to define the area 
at risk at each level, the end-diastolic frame of the postin•
jection cycle showing the best delineation between contrast•
enhanced and non-contrast-enhanced myocardium was se•
lected for analysis. To quantitate the area at risk for each 
level, we first digitized and measured the area enclosed by 
the epicardium (EPA) using a cursor controlled with a joy 
stick. After this, the area of the left ventricular cavity defined 
by the endocardium was digitized (ENA). Myocardial area 
(MA) was then expressed as EPA - ENA. Next, area at risk 
(AR) was determined for each level. This was taken to be 
the area showing no myocardial enhancement (Fig. 2A) and 
was expressed as a percent of the total myocardial area at 
that level using the following equation (16): 
(
AR (cm2)) 
%AR for single level = 0 x 100. 
MA (cm-) 
Wall motion analysis. Wall motion analysis was per•
formed using two separate computer algorithms and two 
blinded observers. The first algorithm is available com•
mercially (Microsonics Corporation). The second algo•
rithm, which has been previously reported (13,14), was 
implemented by interfacing the Microsonics Easy View II 
with a VAX 111780 computer (Digital Equipment Corpo•
ration). 
For the first method of analy::ing wall motion (method 
A), the epicardial and endocardial edges of the left ventricle 
in the pre-contrast short-axis view were manually digitized 
using a joy stick-controlled cursor. This was done for the 
end-diastolic (Fig. 2B, top panel) and end-systolic (Fig. 2B, 
middle panel) frames from the same cardiac cycle. After 
correcting for rotation using a fixed reference (junction of 
posterior wall of the right ventricle with the left ventricle 
A 
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Figure 2. Relation between wall motion abnormahty and area at 
fisk measured by contrast echocardiography after left circumflex 
artery occlusion: A, The risk area after coronary artery injection 
of contrast agent. B, Wall motion abnormality ju~t before injection 
of contrast agent. The top panel shows the end-diastolic frame, 
the middle panel, the end-systolic frame and the lower panel, 
the computer printout depictmg the circumferential extent of ab•
normal wall motion (method A). 
which had been marked by the observer for each frame), 
the computer calculated an average center of mass from the 
end-diastolic and end-systolic images. From this center of 
mass. 32 equally spaced radii were drawn to intersect the 
endocardial outlines for both frames. End-diastolic (Edr) 
and end-systolic (Esr) endocardial ray lengths were then 
measured. Endocardial motion was assessed along each of 
32 radii using the following equation: 
ractlOna radial change (%) = x 100 F . I ' (Edr - ESr) 
Edr 
Since there is no generally accepted threshold below which 
wall motion is considered abnormal, three different criteria 
for abnormality were tested: a) positive (inward) systolic 
fractional radial change less than 20%; b) positive (inward) 
systolic fractional radial change less than lOo/c; and c) neg•
ative (outward) or no systolic endocardial motion (dyski•
nesia or akinesia). respectively. 
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The circumferential extent of abnormal wall motion (A WM) 
was determined using each of these criteria, The following 
equation was used: 
(
Number of radii) 
Circumferential showing A WM 
extent of = X 100. 
AWM (%) 32 
The second method (method B) of wall motion employed 
in this study integrates the entire course of systolic radial 
motion (J 3.14). This is accomplished by digitizing serial 
endocardial outlines recorded in each field (16.7 ms inter•
vals) from end-diastole to end-systole. The average center 
of area for all digitized fields is computed. Motion of en•
docardial targets along rays drawn at 10° intervals around 
the circumference of the ventricle is then examined by cor•
relating the course of motion of the endocardial targets along 
these rays with the course of normal motion derived from 
pooled data from normal hearts. Rays whose correlation 
coefficients fall outside the 95% confidence limits of normal 
motion are considered abnormal. The circumferential extent 
of abnormal wall motion (A WM) was calculated as follows: 
extent of = g X 100. 
Circumferential (~h::~:r ~ ;J;) 
AWM (%) 36 
Experimental protocol. Baseline steady state aortic and 
left ventricular pressures were recorded and preocclusion 
echocardiographic recordings were obtained before and after 
contrast injection. Of the 11 dogs, 5 underwent left anterior 
descending and 6 left circumflex artery occlusion using the 
prep1aced ties. Echocardiographic and hemodynamic sam•
pling were repeated 3 hours after occlusion. The dogs were 
then killed and the hearts removed. 
Statistical analysis. For each echocardiographic level, 
the relation between the area at risk measured by myocardial 
contrast echocardiography and the circumferential extent of 
abnormal wall motion defined by each of the previously 
defined criteria for abnormality was examined using linear 
regression analysis. When appropriate, the goodness of fit 
was also examined using polynomial regression. The regres•
sion coefficients for each method were then compared using 
a Fisher's Z test. The difference in mean abnormal wall 
motion and area at risk was compared using analysis of 
variance. Because it was judged appropriate to apply the 
Bonferroni correction for multiple comparisons, a proba•
bility (p) value of less than 0.01 was considered significant. 
All data are expressed as mean ± SD. 
To establish interobserver variability for the first method 
of analyzing wall motion, two independent blinded observ•
ers measured the extent of wall motion abnormality in six 
dogs. One observer then repeated the measurements several 
days later to establish intraobserver variability. Inter- and 
intraobserver errors were expressed as the square root of 
the variance using an analysis of variance model (BMDP8V: 
Department of Biostatistics, University of California, Los 
Angeles, revised June 1983). Data concerning inter- and 
intraobserver variability inherent in the second method have 
been previously published (13,14). Our laboratory's expe•
rience with inter- and intraobserver variability for assessing 
area at risk using myocardial contrast echocardiography has, 
likewise, been reported previously (16). 
Results 
Abnormal wall motion. Wall motion abnormality could 
be successfully measured in 53 of the 55 planes using method 
A; in 2 apical planes the endocardium could not be defined 
in either the end-diastolic or the end-systolic frame (Table 
I). The inter- and intraobserver error of measuring wall 
motion by method A was 3.6 and 2.4%, respectively. Wall 
motion abnormality could be successfully measured in 47 
planes using method B; in eight dogs the endocardium could 
not be defined in one or more of the systolic frames used 
to determine wall motion abnormality. In five dogs, it was 
in the apical short-axis view that the analysis could not be 
performed. 
Of the 53 planes analyzed with method.A, 40 demon•
strated abnormal wall motion as defined by a fractional radial 
change of less than 20% along one or more radii; 35 (88%) 
of these showed an area with a fractional radial change of 
less than 10%, while 23 (58%) exhibited akinesia or dys•
kinesia. Of the 47 planes analyzed with method B (analysis 
of the entire systolic contraction sequence), 31 showed ab•
normal wall motion. 
In the 40 planes identified as demonstrating abnormal 
wall motion by method A (using only the end-diastolic and 
end-systolic frames), the extent of the circumference show•
ing less than 20% systolic endocardial excursion was 
36.7 ± 27.2% (mean ± SD) (range 6.3 to 93.8%). In the 
35 planes containing a region with evidence of less than 
10% systolic (inward) endocardial excursion, the circum•
ferential extent of this abnormality was 23.0 ± 20.6% (range 
3.0 to 65.6%). Finally, in those planes with evidence of 
akinesia or dyskinesia, the circumferential extent of the 
abnormality was 11.8 ± 16.4% (range 3.0 to 56.3%). 
In the 31 planes demonstrated by method B (analysis of 
the entire systolic contraction sequence) to have abnormal 
wall motion, the circumferential extent of abnormal wall 
motion was 22.5 ± 20.3% (range 10 to 73%). The pure 
interobserver error of 3.8% using this method has been 
published previously (13,14) and is similar to the interob•
server error using method A. 
Area at risk. All 55 short-axis views with contrast en•
hancement were adequate for analysis of risk area, although 
some had been considered inadequate for analysis of wall 
motion. This disparity occurred because the injection of 
Table 1. Measurement of Wall Motion Abnormality in II Dogs 
Dog 
No. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Short-Axis 
Level 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Apex 
LPM 
HPM 
Chordal 
MY 
Area at 
RIsk (%) 
o 
375 
44.9 
46.2 
54.4 
o 
24.6 
45.3 
32.4 
29.9 
44.3 
488 
48.9 
154 
208 
o 
22.1 
21.4 
19.4 
20.3 
11.4 
174 
11.5 
18.9 
15.3 
o 
25.2 
o 
o 
o 
69.1 
80.0 
33.6 
o 
o 
76.0 
51.8 
19.6 
o 
o 
273 
28.7 
o 
o 
o 
54.7 
34.0 
o 
o 
o 
61.0 
31.4 
o 
o 
o 
<20% EE 
o 
62.5 
56.3 
56.6 
68.7 
o 
40.6 
44.0 
438 
75.0 
52.0 
59.4 
71 8 
28.1 
37.5 
NA 
438 
53.1 
520 
50.0 
190 
28.1 
67.0 
41 0 
37.0 
NA 
31 3 
o 
o 
188 
50.0 
59.4 
21 8 
o 
6.3 
59.4 
81.2 
40.6 
o 
18.8 
50.0 
810 
28.1 
o 
o 
93.8 
53.1 
250 
o 
o 
65.6 
625 
o 
o 
o 
Method A 
<10% EE 
o 
50.0 
37.5 
500 
50.0 
o 
31.3 
19.0 
34.3 
28.1 
47.0 
53.1 
468 
12.5 
21.8 
NA 
31.2 
21.8 
470 
22.0 
3.0 
18.7 
15.6 
330 
31.0 
NA 
21.8 
o 
o 
o 
468 
538 
12.6 
o 
o 
50.0 
65.6 
25.0 
o 
o 
25.0 
34.3 
o 
o 
o 
40.6 
406 
o 
o 
o 
59.4 
50.0 
o 
o 
o 
akJdk 
o 
406 
188 
25.0 
o 
o 
250 
o 
3.0 
6.3 
44.0 
31 3 
125 
o 
o 
NA 
28.1 
o 
33.0 
o 
o 
o 
o 
25.0 
21.8 
NA 
o 
o 
o 
o 
35.0 
28 I 
o 
o 
o 
21.8 
53.1 
125 
o 
o 
63 
o 
o 
o 
o 
31 3 
31.3 
o 
o 
o 
56.3 
37.5 
o 
o 
o 
Method B 
o 
NA 
37.0 
47.0 
47.0 
NA 
o 
43.0 
31.0 
28.0 
550 
54.0 
37.0 
26.0 
26.0 
NA 
22.0 
210 
210 
20.0 
10.0 
25.0 
26.0 
210 
26.0 
NA 
35.0 
20.0 
o 
o 
NA 
73.0 
o 
o 
o 
NA 
59.0 
14.0 
o 
o 
34.0 
310 
o 
o 
o 
60.0 
47.0 
o 
o 
NA 
NA 
29.0 
10.0 
o 
o 
ak = akineSIa: dk = dyskinesia; EE = endocardial excursIOn; HPM = high papillary muscle; LPM = 
low papillary muscle; MY = mitral valve. NA = not applicable 
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contrast medium improved the definition of the epicardial 
and endocardial interfaces. However, for purposes of cor•
relation, only the views in which wall motion analysis could 
be successfully performed were considered. Of the 40 slices 
that demonstrated abnormal wall motion by method A, 35 
showed a segmental decrease in contrast uptake (area at 
risk). The size of the area at risk was 23. I ± 23.5% (range 
11.5 to 80%). Of the 31 short-axis levels that demonstrated 
abnormal wall motion by method B, 29 demonstrated con•
trast-defined areas of hypoperfusion; the size of the risk area 
was 20.8 ± 20.2% (range 11.4 to 80%). The inter- and 
intraobserver errors of measuring area at risk by myocardial 
contrast echocardiography in our laboratory are I. I and 
0.2%, respectively (16). 
Comparison of abnormal wall motion and area at 
risk. When wall motion was analyzed using only the end•
diastolic and end-systolic frames (method A), the relation 
of abnormal wall motion to area at risk varied according to 
the criterion used to define abnormal motion. When a frac•
tional radial change of less than 20% was taken to define 
abnormal wall motion, there was a fair correlation (r = 
0.79, P < 0.0001) between the extent of abnormal motion 
and area at risk (Fig. 3). However, the mean circumferential 
extent of abnormal wall motion determined by this criterion 
significantly overestimated the risk area (36.7 ± 27.2% 
versus 23.1 ± 23.5%, P < 0.001) with the relation between 
abnormal wall motion (A WM) and area at risk (AR) being 
best expressed by the regression equation (A WM = 0.96 
AR + 14.II,SEE = 3.3%). In five planes with no contrast 
Figure 3. Relation between the percent of the ventricular circum•
ference with less than 20% end-diastolic to end-systolic endocar•
dial excursion and area at risk (AR) determined by contrast echo•
cardiography. Abnormal wall motion (AWM) = 0.96AR + 14.11 
(r = 0.79, P < 0.0001, SEE = 3.3)_ Solid line = line of best 
fit; dashed line = line of identity. 
100 
• 
echocardiographic evidence of decreased myocardial per•
fusion, there was abnormal wall motion as defined by this 
criterion. In two of these five planes, the abnormal wall 
motion was perceived to be one echocardiographic level 
above the level with a perfusion defect, in two planes it 
was two levels above and in one plane it was three levels 
above (Table I). 
When akinesia or dyskinesia was taken as the criterion 
for considering wall motion to be abnormal, it markedly 
underestimated the area at risk according to the regression 
equation A WM = 0.48 AR + 0.54 (r = 0.66, p < 0.0001, 
SEE = 2.5) (Fig. 4). Further, although 35 planes dem•
onstrated evidence of decreased perfusion, only 23 (66%) 
showed akinesia or dyskinesia. Although the mean area at 
risk was 23.1 ± 23.5%, the mean circumferential extent 
of akinesia or dyskinesia was only 11.8 ± 16.4%. These 
two values were significantly different (p < 0.001). 
The best correlation between abnormal wall motion and 
area at risk using method A was obtained when a fractional 
radial change of less than 10% was used as the criterion for 
abnormality (p 0.01 versus 20% and akinesia/dyskinesia). 
The relation of abnormal wall motion thus defined and the 
area at risk could be expressed either by a linear regression 
equation (A WM = 0.80 AR + 4.24, r = 0.87, p < 0.001, 
SEE = 2.0%) or by a polynomial regression (A WM = 
-0.01 AR2 + 1.5 AR - 0.14, r = 0.92, P < 0.0001, 
SEE = 1.8%). As depicted in Figure 5, polynomial regres•
sion resulted in a better fit with the data than did linear 
regression. In general, the extent of the ventricular circum•
ference with a fractional radial change of less than 10% 
slightly overestimated the area at risk for risk areas involving 
Figure 4. Relation between the percent of the ventncular circum•
ference showing akinesia or dyskinesia and area at risk determined 
by contrast echocardiography. AWM = 0.48 AR + 0.54 (r = 
0.66, P < 0.0001, SEE = 2.5). Abbreviations and lines of best 
fit as in Figure 3. 
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10 to SO% of the myocardial area. However, this relation 
did not hold when the area at risk was greater than SO%. 
There was no plane in which there was a region with a 
fractional radial change of less than 10% in the absence of 
a contrast-demonstrated area at risk and vice versa. The 
mean area at risk and the mean circumferential extent of 
abnormal wall motion using this criterion were similar (23. 1 
± 23.S% versus 23.0 ± 20.6%, P == NS). 
When method B, which integrates information from the 
entire systolic contraction sequence, was used to identify 
regions with abnormal wall motion, there was a good cor•
relation between the extent of abnormal wall motion and 
the contrast-defined area at risk (AWM == 0.92 AR + 3.0, 
r = 0.92, P < 0.001, SEE = 1.7%) (Fig. 6). One plane 
with an area at risk had no abnormal wall motion as defined 
by this method. This method also demonstrated regions with 
abnormal wall motion in two planes with no contrast-defined 
area at risk; these were located immediately adjacent to 
planes demonstrating contrast-defined risk areas. The mean 
area at risk for the 47 levels, in which this method of ana•
lyzing wall motion could be applied, was 20.8 ± 20.2%. 
This was not significantly different from the mean circum•
ferential extent of abnormal wall motion as defined by this 
method (22.S ± 20.3%). 
Discussion 
In the present study, we employed a canine model of 
acute coronary occlusion to compare the area at risk defined 
by myocardial contrast echocardiography (ischemic zone) 
with the extent of abnormal wall motion detected in the 
same tomographic section. We demonstrated a definite re•
lation between these two parameters, the degree of fit vary•
ing according to the method used to quantitate wall motion. 
The best linear correlation was achieved when wall motion 
was analyzed using a method that considers the entIre sys•
tolic contraction sequence rather than just the end-diastolic 
and end-systolic frames. When only the end-diastolic and 
end-systolic frames were analyzed, we also found a good 
correlation between the area at risk and the proportion of 
the left ventricular wall with a fractional radial change of 
less than 10%. 
Contrast echocardiography in defining area at risk. A 
definite relation between the size of the area at risk for 
necrosis after coronary occlusion and the size of the sub•
sequent infarct has been established (27-33); thus, the abil•
ity to measure this area at risk in both the clinical and the 
experimental setting would be very useful. Until recently, 
however, no method has been available for quantitatmg area 
at risk in the beating heart. The demonstration that myo•
cardial contrast echocardiography can accurately define the 
area at risk for a single tomographic level of the left ventricle 
(16-21) and for the entire left ventricular myocardium ( 16) 
70 
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Figure 5. Relation between the percent of the ventricular circum•
ference with an end-diastolic to end-systolic fractional radial change 
and area at risk determined by contrast echocardiography. Thin 
line = linear relation (A WM = 0.80 AR + 4.2 [r = 0.87, P < 
0.0001, SEE == 2.0]); bold line = polynomial relation 
(AWM = - 0.01 AR2 + 1.47 AR - 0.14 [r = 0.92, P < 0.001, 
SEE = 1.9]); dashed line = line of identity. Abbreviations as 
III Figure 3. 
has now made it possible to measure the ischemic zone in 
VIVO. 
Echocardiography in defining abnormal wall mo•
tion. Abnormal wall motion occurs immediately after coro•
nary occlusion (23) and is an established marker of ischemia 
Figure 6. Relation between abnormal wall motion utilizing the 
entire systolic contraction sequence (correlation method) and the 
area at risk determined by myocardial contrast echocardiography. 
AWM = 0.92 AR + 3.04 (r = 0.92, P < 0.001, SEE = 1.7). 
Abbreviations and lines of best fit as in Figure 3. 
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and infarction. The assessment of wall motion also provides 
a direct measurement of the functional effect of the zone of 
decreased perfusion on overall left ventricular performance. 
The echo contrast-defined area at risk and wall motion, 
therefore, are complementary parameters, and an under•
standing of the relation of the area at risk to the extent of 
abnormal wall motion is critical. Aithough several inves•
tigators (6-14) have studied the relation of the extent of 
echocardiographically defined abnormal wall motion to in•
farct size, data relating abnormal wall motion to the in vivo 
area at risk are limited. Using an echocatdiographic contrast 
technique, Armstrong et al. (19) reported that the area at 
risk differed from the distribution of regional wall motion 
abnormalities, but they did not present data to support this 
contention. In contrast, Tei and coworkers (20,21) com•
pared the perfusion territory of a coronary artery, as mea•
sured by contrast echocardiography, with abnormal wall 
motion after coronary occlusion and found a good corre•
lation between area at risk and the circumferential extent of 
abnormal wall motion; however, their criterion for abnormal 
wall motion was not defined. Kemper et al. (21) also found 
a fair correlation between abnormal wall motion and area 
at risk, but in their studies only visual assessment of wall 
motion was performed. 
The present study was, therefore, undertaken to deter•
mine the relation between area at risk and abnormal wall 
motion as assessed using quantitative methods of wall mo•
tion analysis. Unfortunately, there is no accepted definition 
of abnormal wall motion as assessed by two-dimensional 
echocardiography (~2). Some investigators (5) use only 
akinesia or dyskinesia to define abnormal wall motion; oth•
ers (1,3,4,6-12) include hypokinesia as well. Because the 
measured circumferential extent of abnormal wall motion 
will thus depend on the definition of abnormality, we com•
pared the area at risk with several methods of defining ab•
normal wall motion. These included akinesia or dyskinesia, 
hypokinesia as defined by a fractional radial change of less 
than 10 or 20% and a previously published method of anal•
ysis that utilizes the entire systolic contraction sequence 
(13,14). 
Area at risk versus abnormal wall motion using only 
two frames. Our results demonstrate that the relation be•
tween the extent of abnormal wall motion and the area at 
risk depends on the method of wall motion analysis em•
ployed. When we considered a systolic fractional radial 
change of less than 20% to be abnormal, we found a poor 
correlation between abnormal wall motion and area at risk. 
Further, using this criterion, the area at risk was greatly 
overestimated. Moreover, in five planes with no evidence 
of a perfusion defect, regions showing less than 20% en•
docardial excursion were present. Significantly, in two of 
these five planes, the area of decreased endocardial excur•
sion was present one echocardiographic level above an isch•
emic zone. This finding is not unexpected when a highly 
sensitive criterion for abnormality is used, because this de•
scribes the short-axis span of abnormal function as extending 
well beyond the margins of the ischemic zone. Using such 
a method, it would be expected that the abnormal zone of 
function would extend beyond the infarct in all directions 
and, accordingly, a short-axis plane intersecting the ven•
tricle just above or below the ischemic zone may record 
dysfunction but not contrast-defined ischemia. When we 
considered akinesia or dyskinesia as our criterion for ab•
normality, the area at risk was markedly underestimated. 
However, the presence of akinesia or dyskinesia was very 
specific for the presence of a perfusion defect. 
When only end-diastolic and end-systolic frames were 
analyzed, the best correlation between the area at risk and 
abnormal wall motion was obtained when endocardial ex•
cursion of less than 10% was considered abnormal. This 
relation, however, appeared to break down in the few cases 
in which area at risk was greater than 50% of the total 
myocardial cross-sectional area, a phenomenon occurring 
commonly at either the apical or low papillary muscle levels. 
There are several possible explanations for this observation. 
First, endocardium at the apical level was most difficult to 
define. Second, the largest amount of translation is seen at 
the apex with the result that any method of measuring wall 
motion that relies on a fixed center of reference may over•
estimate the areas of decreased perfusion if the translation 
vector is directed toward the region of abnormal wall mo•
tion. Third, it is possible that the apical region, which lacks 
the mechanical support of the more basal portion of the left 
ventricle, reacts differently from the rest of the left ventricle 
to mechanical dysfunction. Discordant wall motion in this 
region has been demonstrated even in the absence of coro•
nary disease (26), while clinical and experimental experi•
ence suggests that the apex typically functions as a whole 
without the clear separation into normal and abnormal seg•
ments found at more basal levels. Finally, the estimation 
of area at risk by myocardial contrast echocardiography may 
be less reliable at the apical level than at other levels. Al•
though we previously demonstrated (16) a good correlation 
between contrast echo-defined total left ventricular area at 
risk and that measured by technetium autoradiography, the 
poorest correlation was found at the apical level. 
Area at risk versus abnormal wall motion using all 
systolic frames. In this study, the best correlation between 
the area at risk and abnormal wall motion was obtained 
using method B, which integrates motion over the entire 
systolic contraction sequence. These results were similar to 
our previously reported comparisons of histochemically de•
fined infarct size and abnormal wall motion in which the 
best relation was also achieved by integrating data from the 
entire systolic contraction sequence (13,14). The main rea•
son for this improved correlation appears to be the inherent 
temporal and spatial heterogeneity of contraction within 
ischemic zones, which makes a method that integrates mo-
lACC Vol 7, No 2 
February 1986 383-92 
KALIL ET AL 
IN VIVO COMPARISON OF RISK AREA AND ABNORMAL WALL MOTION 
391 
tion throughout systole more accurate than one based on a 
single fiducial reference (34,35). Using method B, we found 
that the correlation between the area of decreased perfusion 
and abnormal wall motion was good at all levels. Although 
method B also utilizes a fixed center of reference to measure 
wall motion, the average centroid is calculated from all 
systolic frames rather than just end-diastolic and end-sys•
tolic frames. Therefore, although likely to be influenced by 
translation of the entire heart (13,14), method B seems to 
be less sensitive to this phenomenon than is method A. Thi~ 
may account, in part, for the ability of method B to accu•
rately quantitate wall motion even at the low papillary mus•
cle and apical levels where translation is most prominent. 
Although this is the first study comparing an in vivo 
assessment of the area at risk with quantitative echocardio•
graphic estimates of the extent of abnormal wall motion, 
quantitative comparisons have been made between echo•
cardiographic ally determined abnormal wall motion and risk 
area defined using postmortem methods such as coronary 
angiography (5) and perfusion of coronary arteries with dyes 
such as monastral blue (18). In a recent report (5) in which 
risk area measured by postmortem coronary angiography 
was compared with postocclusion wall thickening, thinning 
or lack of thickening was also found to underestimate the 
area at risk. Because thinning or lack of thickening should 
be analogous to akinesia or dyskinesia, the results of this 
study are in agreement with ours. 
Limitations of wall motion analysis. While our ability 
to identify a threshold for dysfunction that correlates closely 
with echo contrast-defined ischemic zones suggests a defi•
nite quantitative relation between function and perfusion, 
the converse (that is, that a specific level of dysfunction can 
be defined that most appropriately discriminates abnormal 
from normal because it correlates with area at risk in our 
model) cannot be concluded. Function clearly varies with 
loading conditions and an absolute level of dysfunction that 
correlates well with area at risk in one physiologic setting 
may fail to do so in another. Our method of correlation, 
which assumed only a constant slope of contraction, should 
theoretically be less affected by loading conditions, but its 
degree of independence has yet to be established. In addition 
to these factors, there are inherent difficulties in quantitating 
wall motion abnormality. Precise endocardial definition is 
crucial for determining abnormal wall motion. That this is 
not possible in all cases and at all levels of the left ventricle 
is clear from our study. Furthermore, when the endocardium 
is defined by experienced observers there is significant in•
terobserver variability dependent on the quality of the im•
ages (36). 
Opacification of the myocardium using echocardio•
graphic contrast unfortunately requires the injection of the 
contrast agent into the coronary circulation or the ascending 
aorta. This obviously makes the technique highly invasive 
and makes repeat studies at widely spaced intervals difficult. 
In addition, despite the absence of pathologic or permanent 
functional sequelae (24) the contrast agent may itself cause 
transient wall motion abnormalities, in part due to micro•
circulatory blockade by the microbubbles present in the 
agitated contrast medium (20,24,25). These factors may, 
therefore, limit the use of this technique in the clinical 
setting. 
Conclusion. Our study suggests a quantitative relation 
between abnormal wall motion as determined by quantita•
tive two-dimensional echocardiography and the area at risk 
determined by myocardial contrast echocardiography. Our 
data further show that the relation between abnormal wall 
motion and risk area depends on the method of analyzing 
wall motion and is best defined when wall motion is ana•
lyzed utilizing the entire systolic contraction sequence. Fur•
thermore, because wall motion during acute ischemia js also 
dependent on the loading condition of the heart which, al•
though influenced by ischemia, may be independent of it, 
the estimation of both abnormal wall motion and area at 
risk may provide a more comprehensive assessment of car•
diac function in myocardial ischemia than is provided by 
the determination of either alone. 
We thank LUI; Guerrero for technical aSSIstance, Kathleen Lundgren for 
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